← Leaderboards
Nathan I Shapiro
Massachusetts General Hospital
$5,352,426
Attributed
$9,141,928
Total exposure
8
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,141,928 · 8
By mechanism
R01$3,695,917 · 2
U01$2,939,546 · 1
R33$1,352,047 · 2
R21$1,154,418 · 3
Top collaborators
- Eric Peter Schmidt7 shared
- Daniel Stuart Talmor7 shared
- Roby Paul Bhattacharyya3 shared
- Michael Filbin3 shared
- Tamar Sofer1 shared
- Kathleen A Stringer1 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Michael Filbin$2,016,949
- Marcia B Goldberg$29,817,146
- Nir Hacohen$29,379,938
- Michelle Ng Gong$11,453,323
- Daniel Irimia$10,350,962
Others in their field
Top investigators on “Sepsis”
- Ian A Wilson · Scripps Research Institute, The$50,300,809
- Vance G Fowler · Duke University$48,391,331
- Alon Singer · Helixbind, Inc.$39,385,728
- Henry F Chambers · Duke University$39,317,414
- Jonathan Michael Dean · University Of Utah$36,397,260
- Rama K Mallampalli · Ohio State University$23,779,171
Research focus
SepsisFunctional DisorderSiteMorbidity - Disease RateCessation Of LifeOrgan FailureCritical IllnessFundingHospitalsLeadProtocols DocumentationCostClinical TrialsIsraelMortalityHomeostasisCaringClinical Research SiteEndotheliumInvestigationAffectSamplingSeptic PatientsOrgan
Grant awards (23)
Optimizing methods of clinical sample processing for scRNA-seq and mechanistic studies in sepsis to enable reliable, reproducible, and high-yield multi-center collection efforts$676,179
R33 · FY2025 · GM
Optimization of a rapid assay to quantify circulating glycosaminoglycans and identify vascular endotypes of sepsis$675,868
R33 · FY2025 · GM
Genetically Linked Metabolites of Sepsis Severity and Mortality$256,785
R21 · FY2025 · HL
Optimization of a rapid assay to quantify circulating glycosaminoglycans and identify vascular endotypes of sepsis$231,535
R21 · FY2024 · GM
Optimizing methods of clinical sample processing for scRNA-seq and mechanistic studies in sepsis to enable reliable, reproducible, and high-yield multi-center collection efforts$199,629
R21 · FY2024 · GM
Optimization of a rapid assay to quantify circulating glycosaminoglycans and identify vascular endotypes of sepsis$248,285
R21 · FY2023 · GM
Optimizing methods of clinical sample processing for scRNA-seq and mechanistic studies in sepsis to enable reliable, reproducible, and high-yield multi-center collection efforts$218,184
R21 · FY2023 · GM
The Impact of Fluid Resuscitation on Glycocalyx Degradation in Septic Shock$378,727
R01 · FY2022 · HL · contact PI
The Impact of Fluid Resuscitation on Glycocalyx Degradation in Septic Shock$398,769
R01 · FY2021 · HL · contact PI
Clinical Centers (CC) for the NHLBI Prevention and Early Treatment of Acute Lung$457,781
U01 · FY2020 · HL
The Impact of Fluid Resuscitation on Glycocalyx Degradation in Septic Shock$414,860
R01 · FY2020 · HL · contact PI
The Impact of Fluid Resuscitation on Glycocalyx Degradation in Septic Shock$490,378
R01 · FY2019 · HL · contact PI
Clinical Centers (CC) for the NHLBI Prevention and Early Treatment of Acute Lung$457,781
U01 · FY2019 · HL
Clinical Centers (CC) for the NHLBI Prevention and Early Treatment of Acute Lung$457,781
U01 · FY2018 · HL
Clinical Centers (CC) for the NHLBI Prevention and Early Treatment of Acute Lung$457,781
U01 · FY2017 · HL
Clinical Centers (CC) for the NHLBI Prevention and Early Treatment of Acute Lung$457,781
U01 · FY2016 · HL
Clinical Centers (CC) for the NHLBI Prevention and Early Treatment of Acute Lung$487,358
U01 · FY2015 · HL
Clinical Centers (CC) for the NHLBI Prevention and Early Treatment of Acute Lung$163,283
U01 · FY2014 · HL
Endothelial Cell Signaling and Microcirculatory Flow in Severe Sepsis$408,253
R01 · FY2011 · HL · contact PI
Endothelial Cell Signaling and Microcirculatory Flow in Severe Sepsis$411,041
R01 · FY2010 · HL · contact PI
Endothelial Cell Signaling and Microcirculatory Flow in Severe Sepsis$415,037
R01 · FY2009 · HL · contact PI
Endothelial Cell Signaling and Microcirculatory Flow in Severe Sepsis$345,523
R01 · FY2009 · HL · contact PI
Endothelial Cell Signaling and Microcirculatory Flow in Severe Sepsis$433,329
R01 · FY2008 · HL · contact PI